The study conducted by Liu et al. identified mutations in CTNNB1 exon 3 as a potential risk factor for recurrence in low-grade, early-stage endometrioid carcinoma and may be involved in the development of some mucinous-type ovarian carcinomas [85,86]. The gene discussed is CTNNB1; the disease is endometrioid adenocarcinoma.